Can we target glucagon in Type 2 Diabetes Management

714 views

Streamed on 10 Dec, 2022, 09:00 PM

ABOUT THIS SESSION

Glucagon is the key hormone, counter-regulating the action of insulin. Type 2 diabetes mellitus is characterized by inappropriate regulation of hepatic glucose production, which may result from an imbalance in the relationship between insulin and glucagon. Can glucagon action be targeted as a possible therapeutic pathway to treat type 2 diabetes? Dr. R Senthil Kumar will answer these questions in our weekly news round-up on 'Can we target glucagon in type 2 diabetes management?'

FACULTY

Dr. R. Senthil Kumar

Assistant Professor - Diabetes and Endocrinology at PSG Hospitals, Coimbatore

Latest Archive Videos

Women exposed to phthalates are at increased risk of developing diabetes

Behavior change programs are linked to a 20% reduction in the risk of developing diabetes in adults with raised blood sugars or pre-diabetes

Infants who are born large for gestational age (LGA) are at risk for perinatal morbidity and metabolic complications

MORE FROM PRACTICE MANAGEMENT

Lipotoxicity linked to stress in skeletal muscle

Inadequate level of vitamins associated with diabetic neuropathy

Sufficient Diet can reduce Inflammation caused by Diabetic Foot

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ

About Us

Medtalks TV

Webinars

CMEs

Terms And Conditions

Conferences